A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
|Articles|July 8, 2015
Sharon L. Bober, PhD, Discusses Changes in Sexual Health for Patients With Cancer
Author(s)Sharon L. Bober, PhD
Sharon L. Bober, PhD, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses changes in sexual health for patients with cancer.
Advertisement
Sharon L. Bober, PhD, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses changes in sexual health for patients with cancer.
Advertisement
Related to this article
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer treatment evolves.
At EONS 2026, a City of Hope nurse practitioner explains how shifting immunotherapy from infusion to injection can free nurse and chair time.
Oncology nurses play a key role guiding patients about AI breast cancer risk assessment tools, dynamic re-testing, and individualized screening plans.
Dana-Farber nurse practitioners outline ADC patient selection, sequencing, ILD surveillance, and patient education from JADPRO Live 2026.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
2
How Oncology Nurses Can Overcome Common Barriers to Research
3
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
4
Vicarious Trauma Affects Oncology Nurses in Every Care Setting
5